SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3,368,244
-76.1%
21,318
-81.7%
0.13%
-79.0%
Q3 2023$14,100,189
-83.0%
116,319
-84.0%
0.61%
-80.1%
Q2 2023$83,175,303
+87.9%
726,295
+126.1%
3.08%
+69.2%
Q1 2023$44,272,236
+104.6%
321,209
+92.4%
1.82%
+33.2%
Q4 2022$21,638,564
+140.9%
166,990
+102.8%
1.37%
+12.4%
Q4 2018$8,984,000
-63.2%
82,327
-45.5%
1.22%
-26.3%
Q3 2018$24,384,000
+218.1%
150,974
+160.3%
1.65%
+93.7%
Q2 2018$7,666,000
-13.8%
58,000
-51.7%
0.85%
-32.2%
Q1 2018$8,891,000
+3.1%
120,000
-22.6%
1.26%
+11.2%
Q4 2017$8,624,000155,0001.13%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 87,180$2,581,0003.60%
Perceptive Advisors 1,771,029$52,422,0002.99%
SPHERA FUNDS MANAGEMENT LTD. 483,047$14,298,0002.80%
HealthCor Management, L.P. 1,550,000$45,880,0002.10%
Camber Capital Management LP 1,350,000$39,960,0001.62%
Tourbillon Capital Partners, L.P. 1,537,518$45,511,0001.17%
Elk Creek Partners, LLC 562,522$16,651,0001.02%
EMERALD ADVISERS, LLC 818,705$24,234,0001.00%
EMERALD MUTUAL FUND ADVISERS TRUST 604,467$17,892,0000.82%
Carlson Capital, L.P. 1,845,702$54,633,0000.70%
View complete list of SAREPTA THERAPEUTICS INC shareholders